                         SEQUENCE LISTING

<110>  THE NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD.
       BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT
        AUTHORITY LTD.
 
<120>  SHORT PEPTIDES DERIVED FROM VDAC1, COMPOSITIONS AND METHODS OF USE THEREOF

<130>  VDC/002 PCT

<150>  61/858125
<151>  2013-07-25

<160>  25    

<170>  PatentIn version 3.5

<210>  1
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  1

Met Ala Val Pro Pro Thr Tyr Ala Asp Leu Gly Lys Ser Ala Arg Asp 
1               5                   10                  15      


Val Phe Thr Lys Gly Tyr Gly Phe Gly Leu 
            20                  25      


<210>  2
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide


<220>
<221>  misc_feature
<222>  (2)..(4)
<223>  Xaa can be any amino acid

<400>  2

Gly Xaa Xaa Xaa Gly 
1               5   


<210>  3
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  3

Gly Tyr Gly Phe Gly 
1               5   


<210>  4
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  4

Arg Asp Val Phe Thr Lys Gly Tyr Gly Phe Gly Leu 
1               5                   10          


<210>  5
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  5

Thr Lys Gly Tyr Gly Phe Gly Leu 
1               5               


<210>  6
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  6

Gly Lys Ser Ala Arg Asp Val Phe Thr Lys Gly Tyr Gly Phe Gly Leu 
1               5                   10                  15      


<210>  7
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  7

Pro Thr Tyr Ala Asp Leu Gly Lys Ser Ala Arg Asp Val Phe Thr Lys 
1               5                   10                  15      


Gly Tyr Gly Phe Gly Leu 
            20          


<210>  8
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Drosophila antennapedia (Antp) domain

<400>  8

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


<210>  9
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  9

Arg Asp Val Phe Thr Lys Gly Tyr Gly Phe Gly Leu Arg Gln Ile Lys 
1               5                   10                  15      


Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
            20                  25              


<210>  10
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  10

Thr Lys Gly Tyr Gly Phe Gly Leu Arg Gln Ile Lys Ile Trp Phe Gln 
1               5                   10                  15      


Asn Arg Arg Met Lys Trp Lys Lys 
            20                  


<210>  11
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  11

Gly Lys Ser Ala Arg Asp Val Phe Thr Lys Gly Tyr Gly Phe Gly Leu 
1               5                   10                  15      


Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
            20                  25                  30          


<210>  12
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  12

Pro Thr Tyr Ala Asp Leu Gly Lys Ser Ala Arg Asp Val Phe Thr Lys 
1               5                   10                  15      


Gly Tyr Gly Phe Gly Leu Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg 
            20                  25                  30          


Arg Met Lys Trp Lys Lys 
        35              


<210>  13
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  TIR domain fragment

<400>  13

His Ala Ile Tyr Pro Arg His 
1               5           


<210>  14
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  14

Arg Asp Val Phe Thr Lys Gly Tyr Gly Phe Gly Leu His Ala Ile Tyr 
1               5                   10                  15      


Pro Arg His 
            


<210>  15
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  15

Thr Lys Gly Tyr Gly Phe Gly Leu His Ala Ile Tyr Pro Arg His 
1               5                   10                  15  


<210>  16
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  16

Gly Lys Ser Ala Arg Asp Val Phe Thr Lys Gly Tyr Gly Phe Gly Leu 
1               5                   10                  15      


His Ala Ile Tyr Pro Arg His 
            20              


<210>  17
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  17

Pro Thr Tyr Ala Asp Leu Gly Lys Ser Ala Arg Asp Val Phe Thr Lys 
1               5                   10                  15      


Gly Tyr Gly Phe Gly Leu His Ala Ile Tyr Pro Arg His 
            20                  25                  


<210>  18
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  18

Lys Lys Leu Glu Thr Ala Val Asn Leu Ala Trp Thr Ala Gly Asn Ser 
1               5                   10                  15      


Asn 
    


<210>  19
<211>  34
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  19

His Ala Ile Tyr Pro Arg His Ser Trp Thr Trp Glu Lys Lys Leu Glu 
1               5                   10                  15      


Thr Ala Val Asn Leu Ala Trp Thr Ala Gly Asn Ser Asn Lys Trp Thr 
            20                  25                  30          


Trp Lys 
        


<210>  20
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  20

Met Ala Val Pro Pro Thr Tyr Ala Asp Leu Gly Lys Ser Ala Arg Asp 
1               5                   10                  15      


Val Phe Thr Lys Gly Tyr Gly Phe Gly Leu Arg Gln Ile Lys Ile Trp 
            20                  25                  30          


Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
        35                  40          


<210>  21
<211>  36
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  21

Met Ala Val Pro Pro Thr Tyr Ala Asp Leu Gly Lys Ser Ala Arg Asp 
1               5                   10                  15      


Val Phe Thr Lys Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met 
            20                  25                  30          


Lys Trp Lys Lys 
        35      


<210>  22
<211>  43
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  22

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


Ser Trp Thr Trp Glu Lys Lys Leu Glu Thr Ala Val Asn Leu Ala Trp 
            20                  25                  30          


Thr Ala Gly Asn Ser Asn Lys Trp Thr Trp Lys 
        35                  40              


<210>  23
<211>  283
<212>  PRT
<213>  Human VDAC1

<400>  23

Met Ala Val Pro Pro Thr Tyr Ala Asp Leu Gly Lys Ser Ala Arg Asp 
1               5                   10                  15      


Val Phe Thr Lys Gly Tyr Gly Phe Gly Leu Ile Lys Leu Asp Leu Lys 
            20                  25                  30          


Thr Lys Ser Glu Asn Gly Leu Glu Phe Thr Ser Ser Gly Ser Ala Asn 
        35                  40                  45              


Thr Glu Thr Thr Lys Val Thr Gly Ser Leu Glu Thr Lys Tyr Arg Trp 
    50                  55                  60                  


Thr Glu Tyr Gly Leu Thr Phe Thr Glu Lys Trp Asn Thr Asp Asn Thr 
65                  70                  75                  80  


Leu Gly Thr Glu Ile Thr Val Glu Asp Gln Leu Ala Arg Gly Leu Lys 
                85                  90                  95      


Leu Thr Phe Asp Ser Ser Phe Ser Pro Asn Thr Gly Lys Lys Asn Ala 
            100                 105                 110         


Lys Ile Lys Thr Gly Tyr Lys Arg Glu His Ile Asn Leu Gly Cys Asp 
        115                 120                 125             


Met Asp Phe Asp Ile Ala Gly Pro Ser Ile Arg Gly Ala Leu Val Leu 
    130                 135                 140                 


Gly Tyr Glu Gly Trp Leu Ala Gly Tyr Gln Met Asn Phe Glu Thr Ala 
145                 150                 155                 160 


Lys Ser Arg Val Thr Gln Ser Asn Phe Ala Val Gly Tyr Lys Thr Asp 
                165                 170                 175     


Glu Phe Gln Leu His Thr Asn Val Asn Asp Gly Thr Glu Phe Gly Gly 
            180                 185                 190         


Ser Ile Tyr Gln Lys Val Asn Lys Lys Leu Glu Thr Ala Val Asn Leu 
        195                 200                 205             


Ala Trp Thr Ala Gly Asn Ser Asn Thr Arg Phe Gly Ile Ala Ala Lys 
    210                 215                 220                 


Tyr Gln Ile Asp Pro Asp Ala Cys Phe Ser Ala Lys Val Asn Asn Ser 
225                 230                 235                 240 


Ser Leu Ile Gly Leu Gly Tyr Thr Gln Thr Leu Lys Pro Gly Ile Lys 
                245                 250                 255     


Leu Thr Leu Ser Ala Leu Leu Asp Gly Lys Asn Val Asn Ala Gly Gly 
            260                 265                 270         


His Lys Leu Gly Leu Gly Leu Glu Phe Gln Ala 
        275                 280             


<210>  24
<211>  36
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  24

Cys Cys Cys Thr Thr Cys Gly Ala Thr Cys Gly Cys Cys Gly Gly Ala 
1               5                   10                  15      


Ala Thr Thr Cys Cys Ala Gly Gly Ala Thr Cys Cys Thr Cys Cys Cys 
            20                  25                  30          


Ala Gly Cys Cys 
        35      


<210>  25
<211>  36
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  25

Gly Gly Cys Thr Gly Gly Gly Ala Gly Gly Ala Thr Cys Cys Thr Gly 
1               5                   10                  15      


Gly Ala Ala Thr Thr Cys Cys Gly Gly Cys Gly Ala Thr Cys Gly Ala 
            20                  25                  30          


Ala Gly Gly Gly 
        35      


